Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
16.04. | EVOME MEDICAL TECHNOLOGIES INC. - 10-K, Annual Report | 1 | SEC Filings | ||
15.04. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
12.04. | Evome Medical Technologies Inc: Evome Medical talks credit agreement with Pathward | 1 | Stockwatch | ||
12.04. | Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled | 54 | GlobeNewswire (Europe) | NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's... ► Artikel lesen | |
05.04. | Evome Medical Technologies has a 360% upside, Leede says | 1 | Cantech Letter | ||
02.04. | Evome Medical Technologies Inc: Evome Medical to sell Simbex for $4.83-million | 1 | Stockwatch | ||
02.04. | Evome Medical Technologies Inc: Evome Medical Technologies to resume at 9 a.m. PT | 1 | Stockwatch | ||
02.04. | Evome Medical Technologies Inc.: Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt | 1 | GlobeNewswire (USA) | ||
02.04. | Evome Medical Technologies Inc: Evome Medical Technologies halted at 8:13 a.m. PT | 1 | Stockwatch | ||
01.04. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | EVOME MEDICAL TECHNOLOGIES INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
01.04. | Evome Medical Technologies Inc: Evome estimates 2023 revenues at $62.6-million | 1 | Stockwatch | ||
01.04. | Evome Medical Technologies Inc.: Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023 | 101 | GlobeNewswire (Europe) | NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announced today preliminary annual financial results for the year ending December 31, 2023.... ► Artikel lesen | |
27.02. | Evome Medical Technologies Inc.: Evome Medical Engages ICP Securities Inc. for Automated Market Making Services | 2 | GlobeNewswire (USA) | ||
23.02. | EVOME MEDICAL TECHNOLOGIES INC. - 8-K, Current Report | 1 | SEC Filings | ||
15.02. | Evome Medical Technologies Inc: Evome adds two to board, says transformation imminent | 1 | Stockwatch | ||
15.02. | Evome Medical Technologies Inc.: Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman | 212 | GlobeNewswire (Europe) | NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") announces the appointment of two senior healthcare executives to its Board of Directors.? Mr.... ► Artikel lesen | |
08.02. | Evome Medical Technologies Inc: Evome Medical extends $3.29M (U.S.) Simbex debt to 2025 | - | Stockwatch | ||
08.02. | Evome Medical Technologies Inc.: Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by | 186 | GlobeNewswire (Europe) | NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") has executed a non-binding letter of intent (LOI) to extend acquisition debt of US$3,294,440... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 53,16 | +1,92 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
FRESENIUS | 27,530 | -0,47 % | Andritz, Fresenius, Lufthansa, Südzucker, Volkswagen - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
RXSIGHT | 54,92 | 0,00 % | RxSight, Inc. - 8-K, Current Report | ||
NEWGENIVF GROUP | 2,230 | 0,00 % | NewGenIVF Limited: NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings | BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 23,000 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,800 | 0,00 % | Where Privia Health Gr Stands With Analysts | ||
CARL ZEISS MEDITEC | 101,10 | -1,46 % | Carl Zeiss Meditec: Risiken bei der Prognose | Am 8. Mai wird Carl Zeiss Meditec Zahlen zum zweiten Quartal publizieren. Die Analysten der Deutschen Bank rechnen beim Umsatz mit einem organischen Rückgang um 1 Prozent. Das EBIT soll um 27 Prozent... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,280 | -1,55 % | FMC: Erfolge werden deutlicher | Fresenius Medical Care (FMC) erwirtschaftet derzeit rund 70 Prozent des Umsatzes in den USA. Dabei ist das dortige Geschäft überdurchschnittlich profitabel für FMC. Sollte es in dem Land zu Steuersenkungen... ► Artikel lesen | |
GERRESHEIMER | 102,70 | +0,69 % | AKTIE IM FOKUS: Gerresheimer gefragt nach Stifel-Empfehlung | FRANKFURT (dpa-AFX Broker) - Aktien von Gerresheimer haben am Mittwoch im unentschlossenen Marktumfeld an der MDax-Spitze gelegen. Die Papiere des Spezialisten für Spezialverpackungen gewannen 2,8... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 53,75 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
PROGYNY | 32,370 | 0,00 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
ATRICURE | 23,150 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
LIFESTANCE HEALTH GROUP | 6,110 | 0,00 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 | ||
ADAPTHEALTH | 9,795 | 0,00 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank | ||
LIFEMD | 10,890 | 0,00 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 |